Skip to main content
. 2020 Nov 26;9(12):3827. doi: 10.3390/jcm9123827
AA allergic asthma
AHR airway hyperresponsiveness
AIT allergen immunotherapy
AR allergic rhinitis
ARA atopic respiratory allergy
BAC bronchial allergen challenge
BAT basophil activation test
BD test bronchodilator test
ECP eosinophil cationic protein
εCSR class switch recombination to IgE
FcεRI high affinity receptor for IgE
FeNO fractional exhaled nitric oxide
FEV1 forced expiratory volume in the 1st second
FnNO fractional nasal nitric oxide
GINA global initiative for asthma
HC healthy non-atopic control
HDM house dust mite
ICSIg inhaled corticosteroidsimmunoglobulin
IL interleukin
IL-4Rα α subunit of IL-4 receptor
IL-5Rα α subunit of IL-5 receptor
LAA local allergic asthma
LAR local allergic rhinitis
LRA local respiratory allergy
NAC nasal allergen challengenasal allergen challenge
NAR non-allergic rhinitis
NK cell natural killer cell
SQ-HDM standardized quality brand-specific unit denoting the biological power of the extract
SCIT subcutaneous immunotherapy
sIgE allergen-specific IgE
sIgG4 allergen-specific IgG4
SLIT sublingual immunotherapy
SPT skin prick test
sT cell allergen-specific T cell
sTh2 cell allergen-specific Th2 cell
T2 type 2 inflammation